First Eagle Investment Management LLC Acquires New Shares in Progyny, Inc. (NASDAQ:PGNY)

First Eagle Investment Management LLC acquired a new stake in shares of Progyny, Inc. (NASDAQ:PGNY) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 144,900 shares of the company’s stock, valued at approximately $2,500,000.

Other hedge funds also recently modified their holdings of the company. Leibman Financial Services Inc. boosted its holdings in shares of Progyny by 100.7% during the 4th quarter. Leibman Financial Services Inc. now owns 63,509 shares of the company’s stock valued at $1,096,000 after acquiring an additional 31,872 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Progyny by 90.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock valued at $25,319,000 after acquiring an additional 695,740 shares in the last quarter. Aurora Investment Counsel acquired a new stake in shares of Progyny during the 3rd quarter valued at $1,280,000. Clear Harbor Asset Management LLC acquired a new stake in shares of Progyny during the 4th quarter valued at $989,000. Finally, Barclays PLC raised its position in Progyny by 530.4% during the 3rd quarter. Barclays PLC now owns 706,157 shares of the company’s stock worth $11,835,000 after purchasing an additional 594,140 shares during the last quarter. Institutional investors and hedge funds own 94.93% of the company’s stock.

Progyny Trading Up 2.6 %

PGNY stock opened at $20.36 on Friday. The stock has a 50-day moving average price of $21.58 and a 200-day moving average price of $18.64. Progyny, Inc. has a 1-year low of $13.39 and a 1-year high of $38.98. The firm has a market cap of $1.74 billion, a PE ratio of 35.10, a price-to-earnings-growth ratio of 2.39 and a beta of 1.41.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Canaccord Genuity Group raised their target price on Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a research report on Friday, February 28th. Bank of America raised their target price on Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Finally, JPMorgan Chase & Co. raised their target price on Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 28th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $24.82.

Insider Buying and Selling

In related news, CEO Peter Anevski acquired 209,500 shares of the firm’s stock in a transaction on Monday, December 23rd. The stock was purchased at an average cost of $14.48 per share, with a total value of $3,033,560.00. Following the acquisition, the chief executive officer now owns 441,463 shares of the company’s stock, valued at approximately $6,392,384.24. This trade represents a 90.32 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman David J. Schlanger acquired 150,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The shares were bought at an average cost of $14.68 per share, with a total value of $2,202,000.00. Following the completion of the acquisition, the chairman now directly owns 228,269 shares in the company, valued at approximately $3,350,988.92. This represents a 191.65 % increase in their position. The disclosure for this purchase can be found here. 12.30% of the stock is owned by company insiders.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.